Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Chlorzoxazone Tablets USP, 375 mg and 750 mg. This marks Glenmark’s first ANDA approval out of their new North American manufacturing facility based in Monroe, North Carolina.
source https://www.pharmatutor.org/pharma-news/2020/glenmark-pharmaceuticals-receives-anda-approval-for-chlorzoxazone-tablets-usp-375-mg-and-750-mg
No comments:
Post a Comment